Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9

https://doi.org/10.1016/j.bmcl.2018.10.029Get rights and content

Highlights

Abstract

A series of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides were identified as small molecule PCSK9 mRNA translation inhibitors. Analogues from this new chemical series, such as 4d and 4g, exhibited improved PCSK9 potency, ADME properties, and in vitro safety profiles when compared to earlier lead structures.

Section snippets

Acknowledgements

We would like to thank Etzer Darout, Bob Dullea, Steve Coffey, Ed Conn, Brain Samas, and Peter Mueller for their contributions to this work.

References (16)

  • S.W. Park et al.

    J Biol Chem

    (2004)
    D.W. Zhang et al.

    J Biol Chem

    (2007)
    R.M. DeVay et al.

    J Biol Chem

    (2013)
    D. Cunningham et al.

    Nat Struct Mol Biol

    (2007)
    D.E. Piper et al.

    Structure

    (2007)
    P.L. Surdo et al.

    EMBO Rep

    (2011)
  • J.C. Cohen et al.

    N Engl J Med

    (2006)
  • R.P. Giugliano et al.

    J Am Coll Cardiol

    (2015)
  • N.G. Seidah et al.

    Nat Rev Drug Discovery

    (2012)
  • D.N.R. Petersen et al.

    Cell Chem Biol

    (2015)
  • N.G. Lintner et al.

    PLoS Biol

    (2017)
  • A.T. Londregan et al.

    J Med Chem

    (2018)
  • See Supporting...
There are more references available in the full text version of this article.

Cited by (0)

View full text